Cognitive Therapy, Modafinil, Combo All Beneficial for Multiple Sclerosis Fatigue
FRIDAY, Oct. 25, 2024 -- Cognitive behavioral therapy (CBT), modafinil, and their combination are equally beneficial for multiple sclerosis fatigue, according to a study published in the November issue of The Lancet Neurology.
Tiffany J. Braley, M.D., from the University of Michigan in Ann Arbor, and colleagues conducted a randomized, comparative effectiveness trial at two universities in the United States to compare CBT, modafinil, and their combination for the treatment of multiple sclerosis fatigue. A total of 336 adults with multiple sclerosis and problematic fatigue were randomly assigned to receive CBT, modafinil, or both for 12 weeks (114, 114, and 108 individuals, respectively).
The researchers found that CBT, modafinil, and combination therapy were associated with clinically meaningful within-group reductions in the Modified Fatigue Impact Scale (MFIS) of 15.20, 16.90, and 17.30 points, respectively, at 12 weeks. From baseline to 12 weeks, the change in MFIS scores did not differ between the groups; the adjusted total mean difference in MFIS change was 1.88 and 1.20 for CBT and modafinil, respectively, relative to the combination group. For modafinil-containing groups, the most common adverse events included insomnia and anxiety.
"Results of this randomized comparative effectiveness research trial of telephone-based CBT, modafinil, and combination therapy suggest that each treatment offers largely equivalent, clinically meaningful benefits for the effects of multiple sclerosis fatigue in people with multiple sclerosis, with high acceptance, good adherence, and good tolerability," the authors write.
Several authors disclosed ties to the biopharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Long COVID Linked to Abnormal Uterine Bleeding
WEDNESDAY, Sept. 17, 2025 -- Long COVID is associated with abnormal uterine bleeding (AUB), but not with impaired ovarian function, according to a study published online Sept. 16...
Childhood Loneliness Linked to Cognitive Decline in Adulthood
MONDAY, Sept. 16, 2025 -- Childhood loneliness is associated with cognitive decline and dementia risk in adulthood, according to a study published online Sept. 12 in JAMA Network...
Tinnitus Linked to Cognitive Impairment in Older Adults
THURSDAY, Sept. 11, 2025 -- In adults aged 60 years and older, tinnitus, especially severe and prolonged tinnitus, is significantly associated with cognitive impairment, according...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.